Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
17.46 USD | +5.63% | +19.34% | +85.55% |
Feb. 09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
Feb. 07 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
- Stock
- Equities
- Stock Enanta Pharmaceuticals, Inc. - Nasdaq
- News Enanta Pharmaceuticals, Inc.